Journal of the Association of Nurses in AIDS Care
Volume 19, Issue 3 , Pages 225-227, May 2008

Case Presentation: Nephrolithiasis in a Patient Treated With Atazanavir

Of the recently approved antiretroviral protease inhibitors, atazanavir has become a popular medication for the treatment of HIV infection. The advantages of an atazanavir-based regimen include a favorable side effect profile, low impact on lipids, low pill burden, and daily dosing. These have made it a favorable choice for antiretroviral treatment. As more experience is gained with newer antiretroviral medications, additional side effects become apparent. Recent reports have highlighted occurrences of nephrolithiasis in patients using atazanavir-based regimens. The authors present a case of a patient who experienced nephrolithiasis while taking combination antiretroviral therapy that included atazanavir.

Key words: ART, atazanavir, nephrolithiasis, renal colic, urolithiasis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1055-3290(08)00043-5

doi:10.1016/j.jana.2007.11.005

Journal of the Association of Nurses in AIDS Care
Volume 19, Issue 3 , Pages 225-227, May 2008